ADC Therapeutics SA Adjustments For Decrease Increase In Other Current Assets
ADC Therapeutics SA (ADCT) reported Adjustments For Decrease Increase In Other Current Assets of -$5.38 million for the 9-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets · last filed 2023-11-07
- ADC Therapeutics SA adjustments for decrease increase in other current assets for the quarter ending 2023-09-30 was -$3.30M.
- ADC Therapeutics SA adjustments for decrease increase in other current assets for the quarter ending 2023-06-30 was -$1.90M.
- ADC Therapeutics SA adjustments for decrease increase in other current assets for the quarter ending 2023-03-31 was -$175.00K.
- ADC Therapeutics SA adjustments for decrease increase in other current assets for the quarter ending 2022-12-31 was $2.60M.
| Period end | Adjustments For Decrease Increase In Other Current Assets 3 month | Adjustments For Decrease Increase In Other Current Assets 6 month | Adjustments For Decrease Increase In Other Current Assets 9 month | Adjustments For Decrease Increase In Other Current Assets 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$3.30M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | -$5.21M derived: sum of 2 quarters · filed 2023-11-07 | -$5.38M 6-K · filed 2023-11-07 | -$2.78M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | -$1.90M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | -$2.08M 6-K · filed 2023-08-08 | $517.00K derived: sum of 3 quarters · filed 2023-08-08 | -$1.35M derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-03-31 | -$175.00K 6-K · filed 2023-05-09 | $2.42M derived: sum of 2 quarters · filed 2023-05-09 | $558.00K derived: sum of 3 quarters · filed 2023-11-07 | -$3.37M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-12-31 | $2.60M derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | $733.00K derived: sum of 2 quarters · filed 2023-11-07 | -$3.19M derived: sum of 3 quarters · filed 2023-11-07 | -$3.55M 20-F · filed 2023-03-15 |
| 2022-09-30 | -$1.86M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | -$5.79M derived: sum of 2 quarters · filed 2023-11-07 | -$6.14M 6-K · filed 2023-11-07 | -$11.54M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$3.93M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | -$4.28M 6-K · filed 2023-08-08 | -$9.68M derived: sum of 3 quarters · filed 2023-08-08 | -$9.67M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$355.00K 6-K · filed 2023-05-09 | -$5.75M derived: sum of 2 quarters · filed 2023-05-09 | -$5.75M derived: sum of 3 quarters · filed 2023-05-09 | -$6.71M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$5.40M derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | -$5.39M derived: sum of 2 quarters · filed 2023-03-15 | -$6.36M derived: sum of 3 quarters · filed 2023-03-15 | -$6.36M 20-F · filed 2023-03-15 |
| 2021-09-30 | $7.00K derived: 6-K 9 month − 6-K 6 month · filed 2022-11-08 | -$959.00K derived: sum of 2 quarters · filed 2022-11-08 | -$959.00K 6-K · filed 2022-11-08 | -$5.46M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | -$966.00K derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | -$966.00K 6-K · filed 2022-08-09 | -$5.47M derived: sum of 3 quarters · filed 2023-03-15 | -$5.47M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $0.00 6-K · filed 2022-05-09 | -$4.50M derived: sum of 2 quarters · filed 2023-03-15 | -$4.50M derived: sum of 3 quarters · filed 2023-03-15 | |
| 2020-12-31 | -$4.50M derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | -$4.50M derived: sum of 2 quarters · filed 2023-03-15 | -$4.50M 20-F · filed 2023-03-15 | |
| 2020-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | $0.00 6-K · filed 2021-11-02 | ||
| 2020-06-30 | $0.00 6-K · filed 2021-08-03 | |||
| 2019-12-31 | -$3.84M 20-F · filed 2022-03-17 | |||
| 2018-12-31 | -$967.00K 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |